Clinical and neurobiological correlates of DXS1047 genotype in Alzheimer's disease. (Q48153933)

9 February 2018

title

Clinical and neurobiological correlates of DXS1047 genotype in Alzheimer's disease. (English)

1 reference

9 February 2018

0 references

Zubenko GS

1

1 reference

9 February 2018

Hughes HB

series ordinal

2

1 reference

9 February 2018

Stiffler JS

series ordinal

3

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 July 1999

1 reference

9 February 2018

published in

Biological Psychiatry

1 reference

9 February 2018

volume

46

1 reference

9 February 2018

issue

2

1 reference

9 February 2018

page(s)

173-181

1 reference

9 February 2018

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

Alpha-2 macroglobulin is genetically associated with Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

Diagnosis of dementia: Clinicopathologic correlations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

The CYP2D6B allele is associated with a milder synaptic pathology in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

Diffuse Lewy body disease: light and electron microscopic immunocytochemistry of senile plaques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

Radiochemical micro assays for the determination of choline acetyltransferase and acetylcholinesterase activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

Neurologic signs in Alzheimer's disease. Results of a prospective clinical and neuropathologic study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

The Lewy-body variant of Alzheimer's disease. Clinical and pathological findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

The prevalence of dementia: a quantitative integration of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

Diagnosis of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

Parkinson's disease in patients with Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

Alzheimer's disease and Lewy body disease: a comparative clinicopathological study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

Bilateral symmetry of morphologic lesions in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

A physical map of the apolipoprotein gene cluster on human chromosome 19

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

ApoE-epsilon 4 and early-onset Alzheimer's

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

The CYP2D6B mutant allele is overrepresented in the Lewy body variant of Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

Rapid automated analysis of biogenic amines and their metabolites using reversed-phase high-performance liquid chromatography with electrochemical detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

Apolipoprotein E4 allele in a population–based study of early–onset Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

Alzheimer's disease and its Lewy body variant: a clinical analysis of postmortem verified cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

Molecular neurobiology of Alzheimer's disease (syndrome?).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

Platelet membrane fluidity in Alzheimer's disease and major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

Familial risk of dementia associated with a biologic subtype of Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

A genome survey for novel Alzheimer disease risk loci: results at 10-cM resolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

Major depression in primary dementia. Clinical and neuropathologic correlates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

Bilateral symmetry of cholinergic deficits in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

Neurochemical Correlates of Major Depression in Primary Dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

A brain regional analysis of morphologic and cholinergic abnormalities in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

Initial results of a genome survey for novel Alzheimer's disease risk genes: association with a locus on the X chromosome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

Association of the apolipoprotein E epsilon 4 allele with clinical subtypes of autopsy-confirmed Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

Prospective study of risk factors for Alzheimer's disease: results at 7.5 years.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

Family study of platelet membrane fluidity in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

The neuropathology of aminergic nuclei in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

Operational criteria for senile dementia of Lewy body type (SDLT)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900035-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(99)00035-9

1 reference

9 February 2018

PubMed ID

10418691

1 reference

9 February 2018